Descriptive data on additional outcomes included insulin resistance or homeostatic model assessment and insulin resistance (HOMA-IR) (18.9%), oxidized low-density lipoprotein (LDL) (12.1%), pulse-wave velocity (14.3%), intercellular adhesion molecule 1 (ICAM-1) (11.6%), vascular cell adhesion molecule 1 (VCAM-1) (12.1%), interleukin-6 (12.9%), tumor necrosis factor alpha (TNF-alpha) (11.2%), and other outcomes (< 10%). The gene discussed is TNF; the disease is Insulin resistance.